Requirements Federated Learning and mUlti-party computation Techniques for prostatE cancer
0.1.0 - ci-build
Funded by the European Union

Requirements Federated Learning and mUlti-party computation Techniques for prostatE cancer, published by HL7 Europe. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/flute-requirements/ and changes regularly. See the Directory of published versions

: FLUTE Research Study - XML Representation

Raw xml | Download


<ResearchStudy xmlns="http://hl7.org/fhir">
  <id value="RS-ResearchStudyFLUTE"/>
  <text>
    <status value="extensions"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ResearchStudy RS-ResearchStudyFLUTE</b></p><a name="RS-ResearchStudyFLUTE"> </a><a name="hcRS-ResearchStudyFLUTE"> </a><blockquote><p><b>EXT-Datamart</b></p><ul><li>variable: <a href="EvidenceVariable-EV-EvidenceVariableFLUTEGroup.html">EvidenceVariable Group of EvidenceVariables for the FLUTE ResearchStudy</a></li></ul></blockquote><p><b>url</b>: <a href="https://flute.com/ResearchStudy/RS-ResearchStudyFLUTE">https://flute.com/ResearchStudy/RS-ResearchStudyFLUTE</a></p><p><b>name</b>: FLUTEResearchStudy</p><p><b>title</b>: FLUTE Research Study</p><p><b>status</b>: Active</p><p><b>primaryPurposeType</b>: <span title="Codes:{http://hl7.org/fhir/research-study-prim-purp-type treatment}">Treatment</span></p><p><b>phase</b>: <span title="Codes:{https://flute.com/CodeSystem/COS-ResearchStudyPhase initial}">Initial Phase</span></p><p><b>studyDesign</b>: <span title="Codes:{http://hl7.org/fhir/study-design SEVCO:01001}">Interventional research</span></p><p><b>keyword</b>: <span title="Codes:">Prostatic Cancer</span>, <span title="Codes:">Family History</span>, <span title="Codes:">Prostatic-Specific Antigen</span>, <span title="Codes:">DRE</span></p><p><b>description</b>: </p><div><p>A study to evaluate the impact of family history on prostatic cancer follow-up criterias, such as level of prostatic-specific antigen and DRE.</p>
</div><p><b>period</b>: 2025-01-01 --&gt; 2025-12-31</p><h3>AssociatedParties</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Name</b></td><td><b>Role</b></td></tr><tr><td style="display: none">*</td><td>Research Coordinator</td><td><span title="Codes:{http://hl7.org/fhir/research-study-party-role general-contact}">general-contact</span></td></tr></table><h3>Recruitments</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Eligibility</b></td></tr><tr><td style="display: none">*</td><td><a href="EvidenceVariable-EV-InclusionCriteriaFLUTE.html">EvidenceVariable Inclusion Variable for FLUTE Study</a></td></tr></table></div>
  </text>
  <extension url="https://www.isis.com/StructureDefinition/EXT-Datamart">
    <extension url="variable">
      <valueReference>🔗 
        <reference value="EvidenceVariable/EV-EvidenceVariableFLUTEGroup"/>
        <identifier>
          <system value="https://flute.com/EvidenceVariable"/>
          <value value="EvidenceVariableFLUTEGroup"/>
        </identifier>
      </valueReference>
    </extension>
  </extension>
  <url value="https://flute.com/ResearchStudy/RS-ResearchStudyFLUTE"/>
  <name value="FLUTEResearchStudy"/>
  <title value="FLUTE Research Study"/>
  <status value="active"/>
  <primaryPurposeType>
    <coding>
      <system value="http://hl7.org/fhir/research-study-prim-purp-type"/>
      <code value="treatment"/>
      <display value="Treatment"/>
    </coding>
  </primaryPurposeType>
  <phase>
    <coding>
      <system value="https://flute.com/CodeSystem/COS-ResearchStudyPhase"/>
      <code value="initial"/>
      <display value="Initial Phase"/>
    </coding>
  </phase>
  <studyDesign>
    <coding>
      <system value="http://hl7.org/fhir/study-design"/>
      <code value="SEVCO:01001"/>
      <display value="Interventional research"/>
    </coding>
  </studyDesign>
  <keyword>
    <text value="Prostatic Cancer"/>
  </keyword>
  <keyword>
    <text value="Family History"/>
  </keyword>
  <keyword>
    <text value="Prostatic-Specific Antigen"/>
  </keyword>
  <keyword>
    <text value="DRE"/>
  </keyword>
  <description
               value="A study to evaluate the impact of family history on prostatic cancer follow-up criterias, such as level of prostatic-specific antigen and DRE."/>
  <period>
    <start value="2025-01-01"/>
    <end value="2025-12-31"/>
  </period>
  <associatedParty>
    <name value="Research Coordinator"/>
    <role>
      <coding>
        <system value="http://hl7.org/fhir/research-study-party-role"/>
        <code value="general-contact"/>
      </coding>
    </role>
  </associatedParty>
  <recruitment>
    <eligibility>🔗 
      <reference value="EvidenceVariable/EV-InclusionCriteriaFLUTE"/>
      <identifier>
        <system value="https://flute.com/EvidenceVariable"/>
        <value value="FLUTEInclusionVariable"/>
      </identifier>
    </eligibility>
  </recruitment>
</ResearchStudy>